483
James A. Simon, MDJames A. Simon, MD – FDA 483, May 5, 2023
Record Details
An FDA inspection of James A. Simon, MD, a clinical investigator in Washington, DC, revealed significant deficiencies in the conduct of a clinical investigation and control of investigational devices. The firm failed to ensure subjects met inclusion/exclusion criteria prior to randomization and did not properly account for investigational products. These findings indicate a lack of adherence to study protocols and regulatory requirements for clinical trials.
View Company Profile
ID · 78f01268-b9d9-4369-9e5d-7d8ac22e8959
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.